[go: up one dir, main page]

NO993467D0 - Granules comprising clavulanate and one or more excipients - Google Patents

Granules comprising clavulanate and one or more excipients

Info

Publication number
NO993467D0
NO993467D0 NO993467A NO993467A NO993467D0 NO 993467 D0 NO993467 D0 NO 993467D0 NO 993467 A NO993467 A NO 993467A NO 993467 A NO993467 A NO 993467A NO 993467 D0 NO993467 D0 NO 993467D0
Authority
NO
Norway
Prior art keywords
clavulanate
excipients
granules
Prior art date
Application number
NO993467A
Other languages
Norwegian (no)
Other versions
NO993467L (en
Inventor
Jan Willem Groenendaal
Original Assignee
Gist Brocades Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Bv filed Critical Gist Brocades Bv
Publication of NO993467L publication Critical patent/NO993467L/en
Publication of NO993467D0 publication Critical patent/NO993467D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO993467A 1997-11-17 1999-07-14 Granules comprising clavulanate and one or more excipients NO993467D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17
PCT/EP1998/007225 WO1999025343A1 (en) 1997-11-17 1998-11-09 Granules comprising clavulanate and one or more excipients

Publications (2)

Publication Number Publication Date
NO993467L NO993467L (en) 1999-07-14
NO993467D0 true NO993467D0 (en) 1999-07-14

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993467A NO993467D0 (en) 1997-11-17 1999-07-14 Granules comprising clavulanate and one or more excipients

Country Status (13)

Country Link
EP (1) EP0973520A1 (en)
JP (1) JP2001516365A (en)
CN (1) CN1242705A (en)
AU (1) AU1337999A (en)
BR (1) BR9806280A (en)
CA (1) CA2272402A1 (en)
CO (1) CO4980893A1 (en)
JO (1) JO2082B1 (en)
NO (1) NO993467D0 (en)
PL (1) PL334517A1 (en)
TR (1) TR199901584T1 (en)
WO (1) WO1999025343A1 (en)
ZA (1) ZA9810499B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT412344B (en) * 2001-04-12 2005-01-25 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
AT413983B (en) * 2001-04-12 2006-08-15 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
JP5414146B2 (en) * 2003-05-02 2014-02-12 グロボファーム ファーマツォイティシェ プロドゥクティオンズ − ウント ハンデルスゲゼルシャフト エム．ベー．ハー． Solid pharmaceutical preparation containing levothyroxine and / or liothyronine salt
FI20070521A7 (en) * 2006-11-10 2008-05-11 Atacama Labs Oy Granules, tablets and granulation method
FI20080355A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making tablets containing metformin
FI20080346A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making a tablet containing additives
FI20080351A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with low drug content
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080353A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with extra high drug content
FI20080352A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with high drug content
WO2009135946A1 (en) 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
EP2890366A1 (en) * 2012-08-28 2015-07-08 DSM Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at least one of them is in the form of mini-tablets
JP2014062064A (en) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk Method of producing tablets containing valsartan
JP6141472B2 (en) * 2016-03-02 2017-06-07 大原薬品工業株式会社 Method for producing valsartan-containing tablets
KR20250026366A (en) * 2017-07-05 2025-02-25 노파르티스 아게 Novel pharmaceutical composition
CN110051637A (en) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 Amoxicillin and clavulanate potassium preparation and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (en) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Process for the production of high-dose antibiotic tablets
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DE3887179T2 (en) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmaceutical composition, pharmaceutical granules and process for their preparation.
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
PL334517A1 (en) 2000-02-28
CO4980893A1 (en) 2000-11-27
AU1337999A (en) 1999-06-07
ZA9810499B (en) 1999-05-24
TR199901584T1 (en) 2000-01-21
CN1242705A (en) 2000-01-26
NO993467L (en) 1999-07-14
JP2001516365A (en) 2001-09-25
JO2082B1 (en) 2000-05-21
BR9806280A (en) 2000-02-15
EP0973520A1 (en) 2000-01-26
CA2272402A1 (en) 1999-05-27
WO1999025343A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
NO993467D0 (en) Granules comprising clavulanate and one or more excipients
DK1015434T3 (en) New pyrimidin-4-one and pyrimidin-4-thione as fungicide
DK0906292T3 (en) Triazolylmercaptides and their use as microbicides
DK0815861T3 (en) Sulfonamides and their use
NO990965D0 (en) Therapeutic methods and mixtures containing isoflavones
NO991922L (en) Heteroarlsuccinamides and their use as metalloproteinase inhibitors
DE69836432D1 (en) BILDCODER AND DECODER
NO993868D0 (en) 3-piperidyl-4-oxoquinazoline derivatives and medical preparations containing them
NO971811D0 (en) Bicyclic tetrahydropyrazolopyridines and their use as drugs
DK1019358T3 (en) 3,3-diarylpropylamines, their use and preparation
DK0906301T3 (en) Benzofuryl derivatives and their use
NO995513L (en) N-triazolyl-2-indolecarboxamides and their use as CCK-
NO984761D0 (en) Aminoisoquinolines and aminotienopyridine derivatives and their use as anti-inflammatory agents
NO20000366D0 (en) O-substituted hydroxycoumaranone derivatives as anti-tumor and antimetastasis agents
TR199800117A3 (en) Isaksazol- and crotonacitamide derivatives and their use.
NO995683D0 (en) Vitamin D analogues and their neuronal effects
NO981282D0 (en) Calcitriol derivatives and their uses
NO985891D0 (en) Substituted benzamide derivatives and their use as anticonvulsants
NO984444D0 (en) Benzothiophenes, formulations containing the same, and methods
NO983802D0 (en) Benzothiophenes, formulations containing the same and methods
NO308213B1 (en) Substituted indanylidinacetylguanidines, their use and drugs containing the compounds
NO972256D0 (en) O-Benzyloximeter derivatives and their use as pesticides
NO20003268L (en) Hyperhydrated chiticoline, method and use
NO984921D0 (en) Tienopyridine derivatives and their use
NO983556L (en) Formulation and application

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application